2025-02-01 2026-01-31 2026-01-31 false 15404754 Pmgates Ltd 25990Manufacture of other fabricated metal products not elsewhere classified iso4217:GBP xbrli:pure 154047542025-02-01 154047542026-01-31 154047542025-02-01 2026-01-31 15404754bus:SmallEntities2025-02-01 2026-01-31 15404754bus:AuditExempt-NoAccountantsReport2025-02-01 2026-01-31 15404754bus:FullAccounts2025-02-01 2026-01-31 15404754core:WithinOneYear2026-01-31 15404754core:AfterOneYear2026-01-31 15404754core:WithinOneYear2025-02-01 2026-01-31 15404754core:AfterOneYear2025-02-01 2026-01-31 15404754core:CurrentFinancialInstruments2026-01-31 15404754core:Non-currentFinancialInstruments2026-01-31 15404754core:CurrentFinancialInstruments2025-02-01 2026-01-31 15404754core:Non-currentFinancialInstruments2025-02-01 2026-01-31 15404754core:LandBuildings2025-02-01 2026-01-31 15404754core:FurnitureFittings2025-02-01 2026-01-31 15404754core:OfficeEquipment2025-02-01 2026-01-31 15404754core:Vehicles2025-02-01 2026-01-31 15404754core:PlantMachinery2025-02-01 2026-01-31 15404754core:OtherPropertyPlantEquipment2025-02-01 2026-01-31 15404754core:LandBuildings2026-01-31 15404754core:PlantMachinery2026-01-31 15404754core:Vehicles2026-01-31 15404754core:FurnitureFittings2026-01-31 15404754core:OfficeEquipment2026-01-31 15404754core:OtherPropertyPlantEquipment2026-01-31 15404754core:Right-of-useAssets2025-02-01 2026-01-31 15404754core:Right-of-useAssets2026-01-31 15404754core:Goodwill2025-02-01 2026-01-31 15404754core:PatentsTrademarksLicencesConcessionsSimilar2025-02-01 2026-01-31 15404754core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-02-01 2026-01-31 15404754core:OtherResidualIntangibleAssets2025-02-01 2026-01-31 15404754core:Goodwill2026-01-31 15404754core:DevelopmentCostsCapitalisedDevelopmentExpenditure2026-01-31 15404754core:PatentsTrademarksLicencesConcessionsSimilar2026-01-31 15404754core:OtherResidualIntangibleAssets2026-01-31 15404754dpl:CostSales2025-02-01 2026-01-31 15404754dpl:AdministrativeExpenses2025-02-01 2026-01-31 15404754dpl:DistributionCosts2025-02-01 2026-01-3115404754core:ShareCapital2026-01-31 15404754core:SharePremium2026-01-31 15404754core:RevaluationReserve2026-01-31 15404754core:OtherReservesSubtotal2026-01-31 15404754core:ShareCapitalPreferenceShares2026-01-31 15404754core:CapitalRedemptionReserve2026-01-31 15404754core:OtherCapitalReserve2026-01-31 15404754core:RetainedEarningsAccumulatedLosses2026-01-3115404754core:ShareCapital2025-02-01 2026-01-31 15404754core:SharePremium2025-02-01 2026-01-31 15404754core:RevaluationReserve2025-02-01 2026-01-31 15404754core:OtherReservesSubtotal2025-02-01 2026-01-31 15404754core:RetainedEarningsAccumulatedLosses2025-02-01 2026-01-311540475412025-02-01 2026-01-31 1540475422025-02-01 2026-01-3115404754core:ShareCapital12025-02-01 2026-01-31 15404754core:ShareCapital22025-02-01 2026-01-3115404754core:SharePremium12025-02-01 2026-01-31 15404754core:SharePremium22025-02-01 2026-01-3115404754core:RevaluationReserve12025-02-01 2026-01-31 15404754core:RevaluationReserve22025-02-01 2026-01-3115404754core:RetainedEarningsAccumulatedLosses12025-02-01 2026-01-31 15404754core:RetainedEarningsAccumulatedLosses22025-02-01 2026-01-311540475412025-02-01 2026-01-3115404754core:Non-currentFinancialInstrumentscore:CostValuation2025-02-01 15404754core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-01-31 15404754core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-01-3115404754core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-01-31 15404754core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2026-01-31 15404754core:Non-currentFinancialInstrumentscore:CostValuation2026-01-3115404754core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-02-01 15404754core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-01-31 15404754core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-01-31 15404754core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-01-31 15404754core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2026-01-31 15404754core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-01-31 15404754core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2026-01-3115404754core:Non-currentFinancialInstruments2026-01-31 15404754core:Non-currentFinancialInstruments2025-01-31154047542024-02-01 154047542025-01-31 154047542024-02-01 2025-01-31 15404754core:WithinOneYear2025-01-31 15404754core:AfterOneYear2025-01-31 15404754core:CurrentFinancialInstruments2025-01-31 15404754core:Non-currentFinancialInstruments2025-01-31 15404754core:LandBuildings2025-01-31 15404754core:PlantMachinery2025-01-31 15404754core:Vehicles2025-01-31 15404754core:FurnitureFittings2025-01-31 15404754core:OfficeEquipment2025-01-31 15404754core:OtherPropertyPlantEquipment2025-01-31 15404754core:Right-of-useAssets2025-01-31 15404754core:Goodwill2025-01-31 15404754core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-01-31 15404754core:PatentsTrademarksLicencesConcessionsSimilar2025-01-31 15404754core:OtherResidualIntangibleAssets2025-01-31 15404754dpl:AdministrativeExpenses2024-02-01 2025-01-3115404754core:ShareCapital2025-01-31 15404754core:SharePremium2025-01-31 15404754core:RevaluationReserve2025-01-31 15404754core:OtherReservesSubtotal2025-01-31 15404754core:ShareCapitalPreferenceShares2025-01-31 15404754core:CapitalRedemptionReserve2025-01-31 15404754core:OtherCapitalReserve2025-01-31 15404754core:RetainedEarningsAccumulatedLosses2025-01-3115404754core:RetainedEarningsAccumulatedLosses2024-02-01 15404754core:ShareCapital2024-02-01 15404754core:SharePremium2024-02-01 15404754core:RevaluationReserve2024-02-01 15404754core:ShareCapital2024-02-01 2025-01-31 15404754core:SharePremium2024-02-01 2025-01-31 15404754core:RevaluationReserve2024-02-01 2025-01-31 15404754core:OtherReservesSubtotal2024-02-01 2025-01-31 15404754core:RetainedEarningsAccumulatedLosses2024-02-01 2025-01-311540475412024-02-01 2025-01-31 1540475422024-02-01 2025-01-3115404754core:ShareCapital12024-02-01 2025-01-31 15404754core:ShareCapital22024-02-01 2025-01-3115404754core:SharePremium12024-02-01 2025-01-31 15404754core:SharePremium22024-02-01 2025-01-3115404754core:RevaluationReserve12024-02-01 2025-01-31 15404754core:RevaluationReserve22024-02-01 2025-01-3115404754core:RetainedEarningsAccumulatedLosses12024-02-01 2025-01-31 15404754core:RetainedEarningsAccumulatedLosses22024-02-01 2025-01-3115404754bus:Director12025-02-01 2026-01-3115404754bus:Director22025-02-01 2026-01-3115404754bus:PrivateLimitedCompanyLtd2025-02-01 2026-01-31
Pmgates Ltd
Unaudited Financial Statements
for the year ended 31 January 2026
Company registration number 15404754
(England and Wales)

Company Information

For the year ended 31 January 2026
Directors Kulasa, Piotr
Szajstek, Marek Leszek

Registered office Walker House
Market Place
Somerton
TA11 7LZ

Registered number 15404754

Accountant Blue Lias Accounting Limited
Walker House
Market Place
Somerton
Somerset
TA11 7LX

Statement of Financial Position

As at 31 January 2026
Notes
2026
2025
£
£
£
£
Fixed assets
Tangible assets
4
9,779
11,696
9,779
11,696
Current assets
Stocks
5
11,500
8,100
Debtors
6
2,839
2,954
Cash at bank and in hand
7
(1,466)
3,426
12,873
14,480
Creditors
Amounts falling due within one year
8
(26,444)
(33,377)
(26,444)
(33,377)
Net current assets (liabilities)
(13,571)
(18,897)
Total assets less current liabilities
(3,792)
(7,201)
Net assets (liabilities)
(3,792)
(7,201)
Capital and reserves
Called up share capital
9
1,000
1,000
Profit and loss account
(4,792)
(8,201)
Total equity
(3,792)
(7,201)

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 21 October 2026 and are signed on its behalf by:

Kulasa, Piotr
Kulasa, Piotr
Director

Company registration number 15404754

Notes to the Financial Statements

For the year ended 31 January 2026

1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.


Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transaction can be measured reliably.


Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

2.3. Financial instruments

Election and recognition

The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.


Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.


Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in profit or loss.


If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.


Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.


Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.


Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company's contractual obligations expire or are discharged or cancelled.

2.4. Trade and other debtors

Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

2.5. Trade and other creditors

Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

3. Employees

The average number of employees during the year was 3 (2025: 3).

4. Tangible fixed assets

Land and buildings
Plant and machinery
Motor vehicles
Office equipment
Total
£
£
£
£
£
Cost
At 1 February 2025
3,556
4,279
6,375
200
14,410
Additions
-
157
-
-
157
At 31 January 2026
3,556
4,436
6,375
200
14,567
Depreciation and impairment
At 1 February 2025
-
1,070
1,594
50
2,714
Charge for the period
-
841
1,195
38
2,074
At 31 January 2026
-
1,911
2,789
88
4,788
Net book value
At 31 January 2026
3,556
2,525
3,586
112
9,779
At 31 January 2025
3,556
3,209
4,781
150
11,696

5. Stocks and work in progress

2026
2025
£
£
Other stocks
11,500
8,100
Total
11,500
8,100

6. Debtors

2026
2025
£
£
Trade debtors
1
578
Other debtors
1,750
1,750
Prepayments and accrued income
1,088
626
Total due within one year
2,839
2,954
Total due after one year
-
-
Total
2,839
2,954

7. Cash at bank and in hand

2026
2025
£
£
Cash at bank
(1,466)
3,426
Total
(1,466)
3,426

8. Creditors due within one year

2026
2025
£
£
Trade creditors
1,230
1,921
Other creditors
2,401
5,356
Directors loan account
13,821
15,023
Taxation and social security
7,554
8,440
Accruals and deferred income
1,438
2,637
Total
26,444
33,377

9. Share capital

2026
2025
£
£
Allotted, called up and fully paid
Ordinary £1.00
1,000
1,000
Total
1,000
1,000